“…The rationale for these strains was based on their genome availability 22-24 , knowledge of their host interaction capacity 25,26 , their robustness and growth capacity 22,24,26 ( Extended Data Figure 2a) , in addition to information on their safety in humans after oral 27,28,29 , nasal 30 and vaginal 31 high-dose application. L. rhamnosus GG was also selected because of previous reports on its capacity to inhibit the toxic effects of S. aureus on epidermal keratinocytes 32 , its strain-dependent capacity to promote re-epithelialization 33 and to augment tight-junction barrier function in human primary epidermal keratinocytes 34 , and our previous experience with this probiotic strain 25 . For microbiome modulation, C. acnes was targeted as model pathobiont associated with the inflammatory character of acne vulgaris.…”